The FDA was expected to decide on the application of sotorasib and panitumumab for the treatment of metastatic colorectal ...
U.S. consumer groups and two large labor unions urged the U.S. Federal Trade Commission on Thursday to block Novo Holdings, ...
The regulator has delayed its respective decision dates on whether to grant full approval to Amgen’s Lumakras in metastatic ...
The Federal Trade Commission (FTC) and the Department of Justice (DOJ) have released the 2023 Hart-Scott-Rodino (HSR) Annual ...
Behind negative returns for shares of American Express and Merck, the Dow Jones Industrial Average is declining Friday morning. The Dow was most recently trading 138 points lower (-0.3%), as shares of ...
New data released by Merck suggests AstraZeneca and Sanofi’s Beyfortus, the monoclonal antibody injection that protects ...
16hon MSN
Amgen (NASDAQ: AMGN) stock is up 13% this year but has struggled to break out above a tight trading range in recent months.
At the STAT summit, executives discuss their challenges, and hopeful signals, about breaking into markets on obesity and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback